Support Activities for Animal Production (U.S. NAICS 115210): An Investor's Primer

1. Overview

This industry is the for-hire support layer around livestock, poultry, and horses: the farriers who trim and shoe hooves, the technicians who breed cows by artificial insemination (AI — depositing bull semen without natural mating), the firms that sell that semen and the genetics behind it, the crews that shear and dip sheep, the milk-testing and herd-data services, and the barns that board horses. Establishments here are paid a fee or work on contract; they do not own the animals or sell the meat, milk, or foals themselves [1].

Why it matters to an investor: it is a small, cash-light, service-heavy business sitting on top of two very large end markets — the roughly $177 billion U.S. equine economy and the beef/dairy complex — and one high-value slice of it (livestock genetics and reproduction) has real intellectual property, pricing power, and recurring revenue [7][16][29].

Public and private ways in differ sharply. For public-market investors, direct exposure is thin: there is essentially one reasonably pure listed play (Genus plc, in cattle and pig genetics) and a few tangential ones (Zoetis, Neogen, IDEXX Laboratories) touching animal genomics, health, and diagnostics [8][12][14][15]. For private investors the opportunity is larger and more direct — the tens of thousands of farriers, shearers, breeders, and boarding stables, plus the farmer-owned cooperatives and private holding companies that dominate cattle genetics [16][19][30]. The investment case is less about a single headline market-size number and more about recurring customer relationships, biological data, specialized skill, and route density.

2. What it is and how it's structured

NAICS (the North American Industry Classification System) code 115210 covers establishments that perform support activities for raising livestock and other animals on a fee or contract basis. The Census Bureau's own examples include: breeding services (including for companion animals such as cats and dogs); pedigree record services; boarding horses; dairy herd improvement and milk testing; livestock spraying; sheep dipping and shearing; artificial insemination; animal semen banks; bull-testing stations; and branding [1].

In practice the industry splits into a few loosely related businesses:

• Livestock genetics and reproduction — bull/boar studs, semen and embryo sales, AI technician service, embryo transfer, and genomic (DNA) testing. This is the capital- and IP-intensive end.
• Equine services — horse boarding, training, breeding-farm services, and farriery (hoof care and shoeing).
• Field animal-husbandry and herd-data services — sheep shearing and dipping, cattle spraying and branding, milk/forage testing, and similar seasonal or per-head work.

What it excludes (and the adjacent codes): raising the animals themselves is animal production, NAICS 112 (and raising cats, dogs, or pet birds for sale is 112990) [1]. Veterinary care — diagnosis, medicine, surgery — is NAICS 541940, Veterinary Services, and is classified separately even when it serves the same farms [1][4]. Grooming and boarding of pets (dogs, cats) is 812910, Pet Care (except Veterinary) Services. Animal-feed, pharmaceutical, diagnostic, and equipment manufacturing, plus animal transport and general farm management, sit elsewhere. Crop support work is in the sibling group 1151. The line matters for investors: many "animal" businesses people picture (vet clinics, pet boarding, pharma) legally live outside 115210, so a company can sell heavily to animal producers without being classified here.

Ownership mix: overwhelmingly small and private. The U.S. Small Business Administration's (SBA) size standard for this industry is $11 million in average annual receipts — below which a firm counts as "small" — and virtually the entire industry falls under it [5]. Most operators are sole proprietors (a farrier's truck, a one-person AI service, a family boarding barn). At the top end, cattle genetics is concentrated in farmer-owned cooperatives and private holding companies [16][19]. The federal data does not break the industry down by public, private, cooperative, or government ownership; qualitatively the visible market is a mix of local operators, cooperatives, private genetics companies, and work performed in-house by farms.

3. How big it is

Federal business statistics count only the employer slice of this industry — firms with paid employees. On that basis, U.S. County Business Patterns (CBP) for 2023 report [2]:

That works out to average pay near $45,000 per employee [2]. Payroll is not revenue, and the SBA threshold is an eligibility rule, not a size estimate — neither should be used to back into a sales figure. There is no official industry revenue number: agriculture (NAICS 11) is excluded from the Economic Census, so the government publishes payroll, employment, and establishment counts for this code but not receipts, profit, assets, or market share. We do not have an authoritative sales figure and will not invent one.

The undercount is severe here — read this before using the figures above. County Business Patterns misses the bulk of the industry for two reasons. First, CBP measures only employer establishments and by design excludes the self-employed, businesses without an Employer Identification Number, agricultural-production workers, and most government employees [3]. Most of the work here is done by exactly those nonemployer sole proprietors: there are estimated to be well over 25,000 working farriers in the United States alone — more than the entire employee headcount the government reports for the whole industry — and no federal agency even tracks their number, because farriery requires no license [2][30]. Add freelance sheep-shearing crews, independent AI technicians, and small breeders, and the true working population is a large multiple of 23,365. Second, a great deal of animal-support work is done in-house by the farms and ranches themselves (counted under NAICS 112) or by veterinarians (541940), so it never lands in 115210 at all [4]. Treat the CBP numbers as the visible employer floor of a much larger, mostly self-employed workforce, not a full census.

For scale on the commercial end markets these services feed, third-party market-research estimates (broader than the exact NAICS boundary, and to be read as ballparks) put U.S. veterinary/animal artificial-insemination revenue at roughly $2.4 billion in 2024 [22], the global sexed-semen market near $2.8 billion in 2025 [23], and the U.S. horse-boarding market around $6 billion [24].

4. The investable universe

There are very few public ways to own this industry directly. It is, structurally, a private-and-cooperative business.

Public companies with real or adjacent exposure

LSE = London Stock Exchange; NYSE = New York Stock Exchange; OTC = over-the-counter. Zoetis, Neogen, and IDEXX are mostly animal-health, diagnostics, and food-safety companies (different NAICS codes); their tie to 115210 is the genetics/genomics slice. There is no U.S.-listed pure play in farriery, sheep shearing, horse boarding, or AI-technician services, and no dedicated exchange-traded fund (ETF) for the industry.

Major private and cooperative owners (the real center of gravity)

• Select Sires — a federation of U.S. farmer-owned cooperatives; the largest single share of the U.S. dairy-semen market (~31%) [16][17].
• STgenetics (Inguran) — large privately held (family-owned) genetics company (~25.5% U.S. dairy share), focused on bovine genetics, sex-sorted semen, and genomic testing; signed a 2023 letter of intent to combine production and R&D with Select Sires [16][18].
• URUS Group — private/cooperative holding company that rolls up Alta Genetics, GENEX, Trans Ova Genetics, PEAK, Jetstream Genetics, Leachman Cattle, and others, spanning genetics, reproductive technology, and herd-management data [19].
• Dairy One Cooperative — not-for-profit cooperative providing dairy herd information, milk testing, feed/forage analysis, and farm-management data [20].
• Hendrix Genetics — private multi-species breeding company (poultry, swine, aquaculture), backed by Paine Schwartz Partners and its founders [21].
• Tens of thousands of micro-businesses — independent farriers, shearing crews, boarding barns, and breeders, essentially none of them investable as securities [30].

5. How the money works

Owners here get paid a fee for a service — per animal, per breeding dose, per embryo, per herd program, per boarding month, per field job, per lab test, or per data subscription. The strongest models combine several of these streams. Unit economics differ sharply by sub-business:

• Farriers (hoof care). Per-visit or per-horse pricing (a trim or a full set of shoes). It is a labor business with almost no capital — a truck, tools, and a forge — so profit is driven by billable horses per day, price per visit, and travel/route efficiency between farms. Skilled piecework.
• Boarding stables. Monthly board per stall. The economics look like a hotel for horses: revenue is stall occupancy × monthly rate, against largely fixed costs (land, barn, feed, labor). Add-on training, lessons, and coordinating farrier/vet visits lift revenue per stall. Occupancy is the swing variable.
• Field husbandry (shearing, spraying, testing). Per-head piece rates or per-job fees, seasonal and crew-based; margins hinge on animals handled per day and travel.
• Livestock genetics and AI — the high-value end. This is a razor-and-blades, recurring-revenue model: sell semen by the straw and embryos by the unit, charge the AI technician's service fee, and layer on genomic-testing and herd-data fees. Herds re-breed every year, so demand recurs. The genetics owner also has an R&D/IP moat — elite bull "studs," proprietary genomic rankings, and sexed or beef-cross semen that command price premiums — which is what gives the top firms pricing power and margins the pure service trades lack. Key operating metrics are semen units sold, price per unit, genetic-merit rankings (e.g., Total Performance Index or Net Merit dollars), reproductive success, and market share.

Genetics and herd-data businesses scale better than labor-only services because they can own proprietary information, breeding programs, customer records, and IP; labor services are capped by technician hours and route density. Working capital in the genetics end is tied up in semen, embryos, animals, lab supplies, and cold-chain storage.

Across all of it, this is a cyclical, input-cost-sensitive business, not a rate-regulated or asset-heavy one. Demand rises and falls with farmer profitability: when milk and cattle prices are high and feed is cheap, producers invest in better genetics and more services; when they are squeezed or in drought, they cut back and do more in-house. Large integrators and cooperatives can also negotiate hard or self-supply. Equine spending (boarding, farriery) tracks household wealth and is partly discretionary.

6. What drives demand

• Livestock inventories and the cattle cycle. The customer base is the national herd. The U.S. cattle herd is at a multi-decade low — about 86.7 million head as of January 2025, the fewest since 1951, with beef cows around 27.9 million and still declining after years of drought and high costs [25][26]. A smaller herd is a headwind for service volume; a herd-rebuild, when it comes, is a tailwind.
• Dairy strength. Unlike beef, dairy-cow numbers have held up (about 9.57 million head), and dairy is the heaviest user of AI and genetics — supportive for reproduction services [25].
• Beef-on-dairy and sexed semen (the current structural story). Dairy farmers now breed their best cows to sexed semen (to get female replacement heifers) and the rest to beef bulls (to sell higher-value crossbred calves) — a shift supercharged by record calf prices. This premiumizes semen demand even as total units sold slip (U.S. bovine semen sales fell about 4% in 2025 as better fertility and genomics let producers use fewer straws per pregnancy) [27][28]. The direction is toward higher value per unit, not more units.
• Genomic testing and productivity. Cheap DNA testing to rank animals is now standard practice, pulling through genetics services; producers everywhere are chasing more output per unit of feed, labor, and animal [8][27].
• Farm structure and contracting. The U.S. farm base pairs many small family farms (about 86% of farms but 17% of production value in 2024) with a smaller number of much larger operations (midsize/large family farms, ~11% of family farms, ~69% of production). About 26% of total production value came from production under contract, which is especially common in livestock [6]. Small farms support localized and cooperative services; large farms support recurring genetics, data, and herd-management programs — but can also bring work in-house.
• Disease prevention and traceability. Outbreaks create immediate demand for testing, identification, movement records, and replacement animals; USDA has strengthened animal-disease traceability for certain interstate cattle movements [32].
• Equine ownership and wealth. Roughly 6.6 million horses support an equine industry the American Horse Council valued at a $177 billion total economic impact in 2023, tied to 2.2 million jobs — the demand base for boarding and farriery [29].
• Farm consolidation. Fewer, larger operations mean fewer but bigger customers, favoring providers who can serve scale.

7. Regulation

This is a lightly regulated industry at the operator level and a moderately regulated one at the animal-movement and genetics-trade level. It varies substantially by species and service.

• Occupational licensing is minimal. Farriery is unlicensed and untracked in the United States; certification (e.g., through farrier associations) is voluntary [30]. Sheep shearers and boarding operators face no special federal license.
• Animal movement and germplasm trade — USDA APHIS. The U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) regulates interstate movement and the import/export of live animals and germplasm (semen and embryos). Exporters use USDA health certificates issued through the Veterinary Export Health Certification System (VEHCS) and signed by USDA-accredited veterinarians; bovine-embryo exports must be collected by APHIS-approved teams following International Embryo Technology Society (IETS) protocols [31]. APHIS has also strengthened animal-disease traceability requirements (electronic identification for certain interstate cattle and bison) [32]. For genetics companies with global sales, these sanitary rules are a real operating constraint and a barrier to entry.
• Animal Welfare Act (AWA). The AWA and its regulations can require licensing and standards for covered breeders, dealers, exhibitors, and transporters, depending on the animals and business model [33].
• Veterinary oversight of medicated feed. The Food and Drug Administration's (FDA) Veterinary Feed Directive places certain medicated-feed uses under the supervision of a licensed veterinarian [34].
• Pesticide handling. Where services involve agricultural pesticides (spraying, dipping), the Environmental Protection Agency's (EPA) Agricultural Worker Protection Standard and state applicator rules govern training, records, and protective equipment [35].
• Worker safety. The Occupational Safety and Health Administration (OSHA) addresses agricultural hazards — machinery, chemicals, animal handling, heat, and zoonotic disease [36].
• State and local rules. State departments of agriculture oversee animal health and disease reporting; veterinary-practice acts, zoning, waste handling, and insurance also apply. Breed registries and herd-improvement bodies (private, not government) set the pedigree and genetic-evaluation standards that shape the genetics market.
• Emerging: gene editing. Regulatory approval of gene-edited livestock (for example, disease-resistant pigs) sits with the FDA/USDA and is an open frontier that could reshape the genetics end of the industry.

Regulation adds compliance cost but also protects established providers with strong credentials, records, insurance, and biosecurity systems.

8. Competitive dynamics and consolidation

Two very different competitive worlds sit inside one NAICS code.

Genetics is consolidating. Cattle-semen production has concentrated into a handful of players — Select Sires (~31% U.S. dairy share), STgenetics (~25.5%), the ABS division of Genus, and the URUS cooperative/holding structure [8][16][19]. The trend is toward fewer, larger firms: URUS was assembled in 2018; Select Sires and STgenetics signed a letter of intent to combine production and R&D in 2023; and Zoetis agreed in 2026 to buy Neogen's genomics business for $160 million [12][16][19]. This layer is scalable and defensible — it benefits from R&D, proprietary breeding programs, biological inventory, accumulated data, and customer switching costs. Distribution, though, remains fragmented across local cooperatives and independent dealers, and competitive edge comes from genetic merit (whose bulls rank highest), sexed/beef-semen technology, and global reach.

Everything else is atomized. Farriery, boarding, and shearing are classic fragmented, local, relationship-driven service markets with low barriers to entry, no dominant brand, and little consolidation. Trust, animal-handling skill, technician availability, and route density matter more than national branding. It is a plausible (if unglamorous) roll-up opportunity for private buyers — most attractive where operators have recurring contracts and dense territories, least attractive where the business is low-margin labor with easy in-house substitution — and in every case constrained by the skilled-labor bottleneck.

Note that CBP establishment counts are not company counts: one company can operate multiple establishments, and some firms' support work is embedded in other NAICS codes [3].

9. Risks

• Structural herd contraction. A cattle herd at a 75-year low shrinks the addressable base for reproduction and husbandry services; the rebuild timing is uncertain [25][26].
• Volume deflation from efficiency. Better genomics and fertility mean producers need fewer semen units per pregnancy — unit volumes can fall even as demand is "healthy," pressuring providers who sell on volume [28].
• Farm-income cyclicality and input costs. Milk/cattle prices, feed costs, drought, and interest rates swing customer spending on discretionary genetics, boarding, and services.
• Animal-disease shocks. Outbreaks (highly pathogenic avian influenza, bovine diseases, foot-and-mouth risk) can trigger quarantines, halt animal movement, close export markets, and disrupt germplasm trade overnight — even as they raise testing and traceability demand [31][32].
• Labor scarcity and safety. Farriery, AI, and shearing work is physically hard, aging, and has a thin training pipeline — a genuine constraint on service capacity and any roll-up thesis; animal handling, chemicals, and vehicles also carry liability [30][36].
• Customer concentration. Farm consolidation shifts bargaining power to a few large dairies, integrators, and cooperatives that can pressure pricing or self-supply.
• Trade and sanitary barriers. Genetics exporters depend on cross-border health certification; tariffs or new disease restrictions can shut lanes [31].
• Biological, data, and IP risk. Poor breeding outcomes, contamination, mishandled animals, or inaccurate records invite litigation and lost customers; providers must also protect genetic information, customer data, and proprietary methods.
• Discretionary equine spend. Boarding and farriery demand softens with household wealth in downturns.
• Technology disruption. On-farm DIY insemination, genomics commoditization, and gene editing could reset margins and competitive positions.
• Measurement risk. Employer-based federal statistics omit large portions of activity, making market sizing and share analysis unusually hard [3].

10. How to invest, and the outlook

Public routes (thin). The most direct listed exposure is Genus plc (LSE: GNS / OTC: GENSF), whose ABS unit is the global leader in cattle genetics and AI services and whose PIC unit leads pig genetics — a genuine IP-and-recurring-revenue business, though it carries the cyclicality of farm income [8][9]. Zoetis (NYSE: ZTS), Neogen (NASDAQ: NEOG), and IDEXX (NASDAQ: IDXX) give broader, adjacent exposure through animal genomics, medicines, and diagnostics — economics driven more by products, instruments, and consumables than by field-service work, and note that ownership of the genomics business is itself in motion via the 2026 Zoetis–Neogen deal [12][13][14][15]. Beyond these, animal-protein producers, processors, and farm-equipment names touch adjacent segments but sit in other industries; there is no pure-play boarding, farrier, or AI-services stock and no dedicated ETF. Useful public-market diligence: segment revenue by species, recurring versus transactional sales, R&D spend, regulatory and export exposure, customer concentration, cash conversion, and the share of earnings tied to the United States.

Private routes (where the industry actually is). This is a private-markets and operator's game: buying or building a boarding or breeding operation; backing a genetics, reproductive-technology, or herd-data company; or attempting a roll-up of fragmented equine or husbandry services (bounded by the labor bottleneck). The most attractive private targets tend to have recurring herd/lab/data contracts, dense service territories and high technician utilization, proprietary genetics or outcome data, limited customer concentration, low claims history with strong biosecurity, and clear ownership of customer data and IP. The largest genetics players — Select Sires (a farmer-owned cooperative, so membership rather than tradable equity), STgenetics (private), URUS (private/cooperative), Dairy One (cooperative), and Hendrix Genetics (private) — are not open to ordinary equity investors, which is itself a defining feature of the industry [16][18][19][20][21].

Outlook (forward-looking judgment). Near-term, the mix looks favorable at the high-value end even with a shrinking herd: dairy stability, record cattle-market economics, and the beef-on-dairy/sexed-semen shift push demand toward premium genetics, offsetting flat-to-down unit volumes [27][28]. The swing factor over several years is the cattle herd — a rebuild would broaden the base, continued contraction would cap it. The equine side looks resilient given a $177 billion footprint [29], and consolidation among genetics majors is likely to continue. Two wildcards could re-rate the genetics end: regulatory approval of gene-edited, disease-resistant livestock, and further ownership shuffling among the majors. The persistent constraints — skilled-labor scarcity and herd size — are unlikely to ease quickly. Overall the outlook is constructive but selective: the best returns are more likely to come from scalable genetics, reproductive technology, and data platforms than from undifferentiated labor-only services, and investors should underwrite individual operators rather than rely on a single headline market-size number.

---

Sources

1. U.S. Census Bureau, "2022 NAICS Definition — 115210 Support Activities for Animal Production," 2022. https://www.census.gov/naics/?input=115210&year=2022
2. U.S. Census Bureau, "County Business Patterns 2023" (NAICS 115210: 4,791 establishments; 23,365 employees; $1.055B annual payroll; $242.0M Q1 payroll). https://www.census.gov/programs-surveys/cbp.html
3. U.S. Census Bureau, "County Business Patterns — Methodology" (employer-only coverage; excludes self-employed, no-EIN, agricultural-production, and most government workers), 2025. https://www.census.gov/programs-surveys/cbp/technical-documentation/methodology.html
4. U.S. Census Bureau, "541940 — Veterinary Services" (adjacent, separately classified). https://data.census.gov/profile/541940_-_Veterinary_services?codeset=naics~541940
5. U.S. Small Business Administration, "Table of Size Standards," 2023 (NAICS 115210 = $11.0 million average receipts). https://www.sba.gov/document/support-table-size-standards
6. USDA Economic Research Service, "Farm Structure and Organization — Farm Structure and Contracting" (2024: small family farms 86% of farms/17% of output; ~26% of output under contract). https://www.ers.usda.gov/topics/farm-economy/farm-structure-and-organization/farm-structure-and-contracting
7. IBISWorld, "NAICS Code 115210 — Support Activities for Animal Production," 2025. https://www.ibisworld.com/classifications/naics/115210/support-activities-for-animal-production/
8. Genus plc, "Our Businesses — Genus ABS bovine genetics / PIC porcine genetics," 2024. https://www.genusplc.com/about-us/our-businesses/
9. Genus plc, "Preliminary Results for the Year Ended 30 June 2025" (revenue £672.8m), 2025. https://www.genusplc.com/media/cxbeit3p/20250904-genus-fy25-preliminary-results-final.pdf
10. StockAnalysis, "Genus plc (GENSF) Overview" (market cap ~$1.9B), 2026. https://stockanalysis.com/quote/otc/GENSF/
11. Zoetis, "2025 Annual Report," 2026. https://www.zoetis.com/_assets/pdf/corporate/zoetis-2025-annual-report.pdf
12. Zoetis, "Zoetis to Acquire Animal Genomics Business from Neogen" ($160 million), 2026. https://news.zoetis.com/press-releases/press-release-details/2026/Zoetis-to-Acquire-Animal-Genomics-Business-from-Neogen/default.aspx
13. dvm360, "Agreement inked for acquisition of animal genomics business" (Neogen GeneSeek ~$90m sales), 2026. https://www.dvm360.com/view/agreement-inked-for-acquisition-of-animal-genomics-business
14. Neogen Corporation, "Annual Report 2025," 2025. https://www.neogen.com/4a5f08/globalassets/pdfs/annual-reports/annual-report-2025.pdf
15. IDEXX Laboratories, "2024 Form 10-K," 2025. https://ir.idexx.com/sec-filings/all-sec-filings/content/0000874716-25-000037/idxx-20241231.htm
16. The Bullvine, "Stud Wars: Which A.I. Company Holds the Power" (Select Sires ~31%, STgenetics ~25.5% U.S. dairy-semen share; 2023 combination LOI), 2024. https://www.thebullvine.com/a-i-industry/stud-wars-which-ai-company-holds-the-power-in-the-dairy-cattle-genetics-universe/
17. Select Sires, "About Us." https://my.selectsires.com/myselect/about-us
18. STgenetics (Inguran), "About STgenetics." https://www.stgencm.com/default.aspx?language=english
19. URUS Group, "About URUS" (Alta Genetics, GENEX, Trans Ova Genetics, PEAK, and others), 2024. https://urus.org/
20. Dairy One Cooperative, "About Dairy One." https://dairyone.com/about/
21. Hendrix Genetics, "About Us." https://www.hendrix-genetics.com/en/about/
22. MarknTel Advisors, "US Artificial Insemination Market (~$2.4B, 2024)," 2024. https://www.marknteladvisors.com/research-library/us-artificial-insemination-market.html
23. DataIntelo, "Sexed Semen Market Research Report" (global ~$2.8B, 2025), 2025. https://dataintelo.com/report/sexed-semen-market
24. MarketIntelo, "Horse Boarding Facility Market Research Report" (~$6.2B, 2025), 2025. https://marketintelo.com/report/horse-boarding-facility-market
25. Southern Ag Today, "Fewer Cows in 2025" (USDA NASS: 86.66M total cattle Jan 2025; dairy cows 9.57M), 2025. https://southernagtoday.org/2025/02/04/fewer-cows-in-2025/
26. NPR, "Why the U.S. cattle herd is at a 75-year low," 2026. https://www.npr.org/2026/05/29/nx-s1-5719511/beef-cattle-herd-food-prices
27. Dairy Herd Management, "Sexed Semen Surge Meets Beef-on-Dairy Stability," 2025. https://www.dairyherd.com/news/sexed-semen-surge-meets-beef-dairy-stability
28. Cowsmo, "U.S. Bovine Semen Sales Drop 4% in 2025," 2025. https://cowsmo.com/news/u-s-bovine-semen-sales-drop-4-in-2025/
29. American Horse Council, "2023 National Economic Impact Study" ($177B impact; 2.2M jobs; 6.6M horses), 2023. https://horsecouncil.org/economic-impact-study/
30. American Farriers Journal, "No Government Agency Tracks Farrier Numbers" (est. 25,000+ farriers; unlicensed), 2023. https://www.americanfarriers.com/articles/15526-no-government-agency-tracks-farrier-numbers
31. USDA Animal and Plant Health Inspection Service (APHIS), "Live Animal Exports / Veterinary Export Health Certification System (VEHCS)," 2025. https://www.aphis.usda.gov/live-animal-export
32. USDA APHIS, "APHIS Bolsters Animal Disease Traceability in the United States," 2024. https://www.aphis.usda.gov/news/agency-announcements/aphis-bolsters-animal-disease-traceability-united-states
33. USDA APHIS, "Animal Welfare Act and Animal Welfare Regulations," 2023. https://www.aphis.usda.gov/media/document/17164/file
34. U.S. Food and Drug Administration, "Veterinary Feed Directive," 2026. https://www.fda.gov/animal-veterinary/development-approval-process/veterinary-feed-directive-vfd
35. U.S. Environmental Protection Agency, "Agricultural Worker Protection Standard," 2026. https://www.epa.gov/pesticide-worker-safety/agricultural-worker-protection-standard-wps
36. Occupational Safety and Health Administration, "Agricultural Operations — Overview," 2026. https://www.osha.gov/agricultural-operations/